DUSP1 and chronic myelogenous leukemia, BCR-ABL1 positive: Finally, a recent paper has implicated DUSP1/MKP-1 in a growth factor-dependent pathway, which promotes intrinsic resistance to the tyrosine kinase inhibitors (TKI) used to treat chronic myeloid leukemias (CML).